NCT00893945View on ClinicalTrials.gov

Autologous Dendritic Cells Pulsed With Autologous Apoptotic Tumor Cells Administered to Patients With Brain Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Brain Tumors
Interventions
DRUG

DC/AAT

Autologous dendritic cells that have been co-cultured with autologous apoptotic tumor (AAT) specimens.

DRUG

DC/AAT-Flu

Intradermal injection of Autologous dendritic cell vaccine (DC/AAT-Flu) after co-culture with flu-infected AAT

DRUG

DC/KLH

Intradermal injection of Autologous dendritic cell vaccine (DC/KLH) which have been co-cultured with Keyhole pimpit hemocyanin (KLH) as a positive control.

Trial Locations (1)

10065

Rockefeller University, New York

All Listed Sponsors
collaborator

Memorial Sloan Kettering Cancer Center

OTHER

lead

Rockefeller University

OTHER

NCT00893945 - Autologous Dendritic Cells Pulsed With Autologous Apoptotic Tumor Cells Administered to Patients With Brain Tumors | Biotech Hunter | Biotech Hunter